H. TOM SOH, DEPARTMENTS OF RADIOLOGY AND ELECTRICAL ENGINEERING
Attend Dr. Soh's pre-seminar presentation to learn more about Dr. David Tirrell's seminar, "Reinterpreting the Genetic Code - Engineering and Probing Protein Behavior with Non-Canonical Amino Acids", to be held Thursday, May 24th.
JENNIFER ZALLEN, MEMORIAL SLOAN KETTERING CANCER CENTER
The Zallen lab is using molecular, genetic, and cell biological approaches to understand the machinery that directs morphogenetic events. An understanding of the cell rearrangements that occur during normal embryonic development will uncover general principles that build tissues and organs and can provide insight into how deranged versions of these processes contribute to human disease.
PAUL NURSE, THE FRANCIS CRICK INSTITUTE
The goals of Dr. Nurse's laboratory are to better understand the global cellular networks which regulate the eukaryotic cell cycle, cell form and cell growth. These cellular controls are fundamental to the growth, development and reproduction of all living organisms.
NATHANIEL HEINTZ, THE ROCKEFELLER UNIVERSITY
Dr. Heintz will discuss recent studies of molecular mechanisms that regulate specific cell types and circuits in the mammalian brain, and illustrate their role in modulation of complex social and emotional behaviors.
XIAOKE CHEN, DEPARTMENT OF BIOLOGY
Attend Dr. Chen's pre-seminar presentation to learn more about Dr. Nathaniel Heintz's seminar, "The Importance of Cell Type: Molecular Mechanisms of Circuit Modulation in the Mammalian Brain", to be held Thursday, May 3rd.
The Gartner lab seeks to answer questions about how tissue structure forms and functions. They take a synthetic approach, building human tissues from the bottom-up, which allows them to measure and perturb the molecular and physical properties of individual cells, reconstitute them into living tissue, then observe their interactions to reveal the underlying "rules" guiding their collective behaviors.
The Fontan surgical procedure is used to treat children born with particular congenital heart defects, namely to provide a direct connection between the inferior vena cava and the right pulmonary artery. This procedure has proven successful in better oxygenating and delivering blood despite the absence of one ventricle. Tissue engineering promises to enable an improved vascular conduit and is in clinical trials in the USA. There is a need, however, to find an optimal scaffold design that can minimize possible post-operative complications.
ALISON MARSDEN, DEPARTMENTS OF PEDIATRICS AND BIOENGINEERING
Attend Dr. Marsden's pre-seminar presentation to learn more about Dr. Jay Humphrey's seminar, "Computational Model-Driven Design of Tissue Engineered Vascular Grafts", to be held Thursday, April 12th.
The Weissman laboratory is looking at how cells ensure that proteins fold into their correct shape, as well as the role of protein misfolding in disease and normal physiology. They are also developing experimental and analytical approaches for exploring the organizational principles of biological systems and globally monitoring protein translation through ribosome profiling.
Stanford Bio-X is now accepting Letters of Intent for the 9th Round of the Stanford Bio-X Interdisciplinary Initiatives Seed Grants Program!
Letters of Intent must be received by March 19, 2018 at 5:00 pm PST.
